Home > Theranos withdraws Zika test

Theranos withdraws Zika test


The embattled blood testing firm's move comes after regulators found Theranos failed to implement proper patient safeguards in its study. Fred Katayama reports.

Added on the 31/08/2016 16:15:31 - Copyright : Reuters EN

To customise your video :

Or Create an account

More videos on the subject

  • Theranos Running Out Of Money, Unless Its Zika Test Gets Approved

    According to a report by Business Insider, a number of big names who have invested in Theranos stand to lose hundreds of millions from their investments. In December, Theranos said in a letter to investors that it had managed to raise $100 million in financing from investment firm Fortress Investment Group, with the hope that it would help the company survive through 2018. However, by the end of July, Theranos will reportedly fall below the $3 million liquidity line it needed to maintain and will default on its agreement with Fortress, unless it manages to win approval for its Zika test by then. Theranos has been under scrutiny since October 2015, after The Wall Street Journal published an investigation that called into question the accuracy of its blood test. In March, the SEC charged Theranos and its CEO Elizabeth Holmes with fraud, alleging they had made false statements and misled investors while raising $700 million.

    05/05/2018 - Wochit
  • Mysterious Theranos Executive's Lawyer Speaks About Upcoming Trial

    According to a report by Business Insider, the Department of Justice charged Theranos founder Elizabeth Holmes and former Theranos president Sunny Balwani with nine counts of wire fraud and two counts of conspiracy to commit wire fraud on Friday. While Holmes has become synonymous with the blood testing startup fiasco, while Balwani remained mostly behind the scenes leaving a nearly invisible digital footprint. On Friday, Balwani's lawyer, Jeffrey Coopersmith, said in a statement, "Mr. Balwani looks forward to trial because he did not defraud anyone, and it will be an honor to defend him vigorously." The DOJ alleges that Holmes and Balwani falsely claimed to possess technology that could run a full range of blood tests using a small amount of blood more accurately than traditional blood-testing methods.

    23/06/2018 - Wochit
  • Theranos CEO Asking Investors for Money to Save Company

    According to a Buzzfeed report, Theranos CEO Elizabeth Holmes is asking investors for more money to keep the company afloat. In a letter sent out this week, Holmes lays out how Theranos is falling behind on the development milestones it needs under an agreement it has with Fortress Investment Group. Fortress previously provided Theranos, a blood-testing company, with $100 million in funding to get it through this year.

    11/04/2018 - Wochit
  • Hurricane Harvey Puts Texas Healthcare Workers To The Test

    No one single entity has authority over health matters in Texas, which has a history of turning away federal funding and oversight and which has a limited Medicaid program. Now, post-Harvey, medical care providers are overwhelmed. So far, there's no big epidemic to cope with. The Harris County Health Department had to squelch rumors that plague was being spread by flood waters. But there are plenty of other messes left behind by Hurricane Harvey’s floodwaters. They include masses of mosquitoes, respiratory infections and a dramatic worsening of the day-to-day ills that people could cope with in normal times, but that get out of control in a crisis. Other issues victims and care providers face are mental health problems associated with the trauma of the flood, mosquito-borne illnesses like Zika and West Nile virus, and a host of other symptoms brought on by black mold in flooded homes.

    09/09/2017 - Wochit
  • FDA Approves Emergency Use Declaration For Multiplex Zika Test

    Food and Drug Administration has issued an Emergency Use Authorization for the first multiplex test for the Zika virus and three other viruses. The FDA made the authorization for the test developed by the Center for Infection and Immunity at Columbia University's Mailman School of Medicine Monday. This test is the first multiplex test that can detect the Zika virus and all serotypes of dengue virus, chikungunya virus and West Nile virus simultaneously. The authorization does not mean that the FDA has cleared or approved the test, but has cleared it for use by laboratories certified under the Clinical Laboratory Improvement Amendments of 1988. The authorization allows only for the detection of RNA form Zika, dengue, chikungunya and West Nile viruses, not other viruses or pathogens.

    15/08/2017 - Wochit

More videosBusiness

Watch video of Shares Of Blue Apron Dipped To An All-time Low. The Meal-kit Subscription Dropped To $1.81 Per Share On Tuesday. The Company Has Faced Increasing Pressures From Competition, Like HelloFresh. Big Companies Like Walmart And Amazon Entering Its Space. In March, Walmart Announced It Was Launching Its Own Line Of Meal Kits. The Company Has Struggled To Attract New Customers And Retain Old Ones Since Going Public Last June. - Blue Apron Shares Drop To A New Low - Label : Wochit -

Blue Apron Shares Drop To A New Low

03/04/2018 21:21:24